Location: Dallas, TX
CIK: 0001791827 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value: $4.356B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AZN | ASTRAZENECA PLC | 3,499,000 | $231M | 5.3% | $60.76 | — | SPONSORED ADR | 046353108 |
| VRTX | VERTEX PHARMACEUTICALS INC | 793,000 | $223M | 5.1% | $238.59 | +12.2% | COM | 92532F100 |
| ARGX | ARGENX SE | 572,500 | $217M | 5.0% | $359.34 | — | SPONSORED ADR | 04016X101 |
| ELV | ELEVANCE HEALTH INC | 441,000 | $213M | 4.9% | $410.29 | +14.4% | COM | 036752103 |
| AVTR | AVANTOR INC | 6,652,700 | $207M | 4.7% | $29.00 | +7.6% | COM | 05352A100 |
| LLY | LILLY ELI & CO | 610,000 | $198M | 4.5% | $290.91 | 0.0% | COM | 532457108 |
| HUM | HUMANA INC | 412,300 | $193M | 4.4% | $415.86 | +3.1% | COM | 444859102 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 725,600 | $171M | 3.9% | $193.01 | +5.3% | COM | 91307C102 |
| JNJ | JOHNSON & JOHNSON | 900,200 | $160M | 3.7% | $156.74 | +2.0% | COM | 478160104 |
| — | HORIZON THERAPEUTICS PUB L | 1,856,900 | $148M | 3.4% | $82.32 | — | SHS | G46188101 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1,467,600 | $143M | 3.3% | $95.35 | -3.2% | COM | 64125C109 |
| ARVN | ARVINAS INC | 3,355,623 | $141M | 3.2% | $53.70 | -6.6% | COM | 04335A105 |
| XBI | SPDR SER TR | 1,875,000 | $139M | 3.2% | $77.93 | — | S&P BIOTECH | 78464A870 |
| MCK | MCKESSON CORP | 388,800 | $127M | 2.9% | $290.93 | +8.0% | COM | 58155Q103 |
| UNH | UNITEDHEALTH GROUP INC | 242,200 | $124M | 2.9% | $437.42 | +7.7% | COM | 91324P102 |
| ABBV | ABBVIE INC | 755,000 | $116M | 2.7% | $82.28 | +63.0% | COM | 00287Y109 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 5,450,000 | $105M | 2.4% | $18.08 | -7.9% | COM | 87164F105 |
| — | CATALENT INC | 955,000 | $102M | 2.4% | $108.57 | — | COM | 148806102 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 3,585,881 | $101M | 2.3% | $47.41 | -44.1% | COM | 98943L107 |
| — | SEAGEN INC | 550,000 | $97.32M | 2.2% | $170.90 | — | COM | 81181C104 |
| BSX | BOSTON SCIENTIFIC CORP | 2,525,000 | $94.11M | 2.2% | $41.95 | -3.0% | COM | 101137107 |
| BIIB | BIOGEN INC | 440,566 | $89.85M | 2.1% | $215.22 | -5.0% | COM | 09062X103 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 1,479,500 | $88.27M | 2.0% | $74.61 | -17.5% | COM | 90400D108 |
| ACHC | ACADIA HEALTHCARE COMPANY IN | 1,035,000 | $70M | 1.6% | $69.76 | 0.0% | COM | 00404A109 |
| NTLA | INTELLIA THERAPEUTICS INC | 1,125,194 | $58.24M | 1.3% | $62.55 | -18.8% | COM | 45826J105 |
| LEGN | LEGEND BIOTECH CORP | 1,000,000 | $55M | 1.3% | $41.26 | — | SPONSORED ADS | 52490G102 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 1,438,999 | $50.67M | 1.2% | $56.03 | -32.9% | COM | 04280A100 |
| IMCR | IMMUNOCORE HLDGS PLC | 1,350,000 | $50.37M | 1.2% | $38.38 | — | ADS | 45258D105 |
| NTRA | NATERA INC | 1,369,100 | $48.52M | 1.1% | $76.92 | -51.9% | COM | 632307104 |
| — | INTRA-CELLULAR THERAPIES INC | 775,504 | $44.27M | 1.0% | $57.08 | — | COM | 46116X101 |
| IDYA | IDEAYA BIOSCIENCES INC | 2,972,947 | $41.03M | 0.9% | $19.22 | -42.1% | COM | 45166A102 |
| — | BELLUS HEALTH INC NEW | 4,265,000 | $39.41M | 0.9% | $4.36 | — | COM NEW | 07987C204 |
| ALT | ALTIMMUNE INC | 2,981,000 | $34.88M | 0.8% | $11.46 | -46.2% | COM NEW | 02155H200 |
| — | KEZAR LIFE SCIENCES INC | 4,050,000 | $33.49M | 0.8% | $15.08 | — | COM | 49372L100 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,080,200 | $30.23M | 0.7% | $21.27 | -30.0% | COM | 05370A108 |
| — | KARUNA THERAPEUTICS INC | 204,570 | $25.88M | 0.6% | $126.51 | — | COM | 48576A100 |
| RVMD | REVOLUTION MEDICINES INC | 1,325,000 | $25.82M | 0.6% | $19.47 | 0.0% | COM | 76155X100 |
| ARKG | ARK ETF TR | 750,000 | $23.62M | 0.5% | $31.49 | — | GENOMIC REV ETF | 00214Q302 |
| VIR | VIR BIOTECHNOLOGY INC | 758,211 | $19.31M | 0.4% | $41.37 | -43.6% | COM | 92764N102 |
| NKTX | NKARTA INC | 1,414,082 | $17.42M | 0.4% | $13.12 | 0.0% | COM | 65487U108 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,919,800 | $16.2M | 0.4% | $23.34 | -56.0% | COM | 71722W107 |
| CRBU | CARIBOU BIOSCIENCES INC | 2,950,000 | $16.02M | 0.4% | $22.68 | -66.3% | COM | 142038108 |
| — | DECIPHERA PHARMACEUTICALS IN | 1,200,000 | $15.78M | 0.4% | $13.15 | — | COM | 24344T101 |
| NUVB | NUVATION BIO INC | 4,855,000 | $15.73M | 0.4% | $11.06 | -60.6% | COM CL A | 67080N101 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 1,392,300 | $15.37M | 0.4% | $19.94 | -34.3% | COM | 462260100 |
| XENE | XENON PHARMACEUTICALS INC | 450,000 | $13.69M | 0.3% | $30.24 | 0.0% | COM | 98420N105 |
| SIBN | SI-BONE INC | 1,000,000 | $13.2M | 0.3% | $24.11 | -30.9% | COM | 825704109 |
| — | SEASPINE HLDGS CORP | 2,010,000 | $11.36M | 0.3% | $19.29 | — | COM | 81255T108 |
| ATEC | ALPHATEC HLDGS INC | 1,715,000 | $11.22M | 0.3% | $12.16 | -24.2% | COM NEW | 02081G201 |
| APLS | APELLIS PHARMACEUTICALS INC | 215,000 | $9.722M | 0.2% | $44.18 | +3.2% | COM | 03753U106 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 62,000 | $9.673M | 0.2% | $153.94 | 0.0% | SHS USD | G50871105 |
| — | ALPINE IMMUNE SCIENCES INC | 998,565 | $8.498M | 0.2% | $10.31 | — | COM | 02083G100 |
| — | ESSA PHARMA INC | 2,460,000 | $7.749M | 0.2% | $9.93 | — | COM NEW | 29668H708 |
| IPSC | CENTURY THERAPEUTICS INC | 865,000 | $7.266M | 0.2% | $24.33 | -59.7% | COM | 15673T100 |
| ERAS | ERASCA INC | 995,000 | $5.542M | 0.1% | $11.59 | -43.5% | COM | 29479A108 |
| — | CYTEIR THERAPEUTICS INC | 1,850,000 | $5.532M | 0.1% | $20.50 | — | COM | 23284P103 |
| ANTX | AN2 THERAPEUTICS INC | 688,330 | $5.335M | 0.1% | $15.17 | -12.7% | COM | 037326105 |
| CMPX | COMPASS THERAPEUTICS INC | 2,000,000 | $5.3M | 0.1% | $3.29 | -34.0% | COM | 20454B104 |
| — | MEDICUS SCIENCES ACQUISITION | 520,000 | $5.086M | 0.1% | $9.65 | — | CL A SHS | G5960S108 |
| — | BCLS ACQUISITION CORP | 500,000 | $4.95M | 0.1% | $11.14 | — | COM CL A | G0904B105 |
| — | ARYA SCIENCES ACQU CORP IV | 500,000 | $4.905M | 0.1% | $10.47 | — | CL A | G31659108 |
| — | PANACEA ACQUISITION CORP II | 500,000 | $4.88M | 0.1% | $10.02 | — | CL A SHS | G6882C106 |
| S | SENTINELONE INC | 204,500 | $4.771M | 0.1% | $43.12 | -34.9% | CL A | 81730H109 |
| — | IVERIC BIO INC | 430,117 | $4.138M | 0.1% | $14.44 | — | COM | 46583P102 |
| — | HEALTH SCIENCES ACQ CORP 2 | 400,000 | $3.984M | 0.1% | $11.00 | — | ORD SHS | G4411D109 |
| TNGX | TANGO THERAPEUTICS INC | 813,640 | $3.686M | 0.1% | $11.27 | -46.3% | COM | 87583X109 |
| HYPR | HYPERFINE INC | 1,503,754 | $3.353M | 0.1% | $9.78 | -69.9% | COM CL A | 44916K106 |
| — | CAREMAX INC | 755,329 | $2.742M | 0.1% | $12.86 | — | COM CL A | 14171W103 |
| — | PHASEBIO PHARMACEUTICALS INC | 4,405,000 | $2.643M | 0.1% | $3.45 | — | COM | 717224109 |
| — | FIELD TRIP HEALTH LTD | 2,976,000 | $2.5M | 0.1% | $4.59 | — | COM | 31656R102 |
| — | ONCOSEC MED INC | 2,945,000 | $2.185M | 0.1% | $5.54 | — | COM | 68234L306 |
| — | OTONOMY INC | 1,000,000 | $2.08M | 0.0% | $2.40 | — | COM | 68906L105 |
| — | SOCIAL CAP SUVRETTA HLD CRPI | 200,000 | $1.99M | 0.0% | $10.11 | — | CLASS A ORD SHS | G8253W109 |
| — | SOCIAL CAP SUVRETTA HLDS CRP | 200,000 | $1.978M | 0.0% | $10.11 | — | CLASS A ORD SHS | G8253T106 |
| — | GRAPHITE BIO INC | 710,000 | $1.953M | 0.0% | $30.47 | — | COM | 38870X104 |
| — | SOCIAL CAP SUVRETTA HLDS CRP | 200,000 | $1.944M | 0.0% | $10.12 | — | CLASS A ORD SHS | G8253U103 |
| — | SOCIAL CAP SUVRETTA HLDS CP | 200,000 | $1.942M | 0.0% | $10.10 | — | CLASS A ORD SHS | G8253Y105 |
| SCYX | SCYNEXIS INC | 959,524 | $1.785M | 0.0% | $4.78 | -49.7% | COM NEW | 811292200 |
| — | SEMA4 HOLDINGS CORP | 950,000 | $1.197M | 0.0% | $7.59 | — | COM CL A | 81663L101 |
| — | SCIENCE 37 HOLDINGS INC | 430,000 | $864K | 0.0% | $11.87 | — | COM | 808644108 |
| — | NUVATION BIO INC | 99,999 | $28,000 | 0.0% | $2.67 | — | *W EXP 07/07/202 | 67080N119 |
| — | MEDICUS SCIENCES ACQUISITION | 57,770 | $10,000 | 0.0% | $1.00 | — | *W EXP 02/12/202 | G5960S124 |